Inactive Instrument
Company Guided Therapeutics Inc OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Business description: Guided Therapeutics Inc

Sales by Activity: Guided Therapeutics Inc
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Developing Innovative Medical Devices | 81K | 13K | 98K | 7K | 767K |
Executive Committee: Guided Therapeutics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
Composition of the Board of Directors: Guided Therapeutics Inc
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
Richard Blumberg
BRD | Director/Board Member | 69 | 2016-11-09 |
Alan Grujic
BRD | Director/Board Member | 58 | 2023-03-07 |
Company details: Guided Therapeutics Inc
Guided Therapeutics, Inc.
5835 Peachtree Corners East
30092, Peachtree Corners
+770 242 8723
http://www.guidedinc.com
Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.97% | +3.50% | +22.37% | +0.32% | 195B | ||
| +5.87% | +6.59% | -21.20% | +24.59% | 151B | ||
| +2.17% | +2.44% | -2.26% | -17.53% | 140B | ||
| +4.83% | +2.13% | -56.44% | -16.55% | 67.09B | ||
| +2.59% | +5.18% | +22.53% | +0.04% | 54.34B | ||
| +1.39% | +1.63% | -26.28% | -32.59% | 44.64B | ||
| -2.02% | -3.56% | +8.31% | +8.68% | 36.91B | ||
| +0.31% | +0.64% | +7.78% | +42.30% | 37.24B | ||
| +1.09% | +0.96% | -13.87% | -19.29% | 29.82B | ||
| Average | +1.28% | +2.18% | -6.56% | -1.11% | 83.95B | |
| Weighted average by Cap. | +1.55% | +3.35% | -3.59% | +0.10% |
- Stock Market
- Stocks
- GTHP Stock
- Stock
- Company Guided Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions

















